Details for New Drug Application (NDA): 087943
✉ Email this page to a colleague
The generic ingredient in THEO-24 is theophylline. There are thirty-six drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 087943
Tradename: | THEO-24 |
Applicant: | Endo Operations |
Ingredient: | theophylline |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 087943
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
THEO-24 | theophylline | CAPSULE, EXTENDED RELEASE;ORAL | 087943 | ANDA | Endo Pharmaceuticals, Inc. | 52244-200 | 52244-200-10 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (52244-200-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 200MG | ||||
Approval Date: | Aug 22, 1983 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 100MG | ||||
Approval Date: | Aug 22, 1983 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 300MG | ||||
Approval Date: | Aug 22, 1983 | TE: | RLD: | No |
Complete Access Available with Subscription